Douglas N. Dobak
Keine laufenden Positionen mehr
Profil
Douglas N.
Dobak worked as an Executive Director of US Regulatory Affairs at AstraZeneca Pharmaceuticals LP and as a Vice President of Regulatory Affairs & Drug Safety at NPS Pharmaceuticals, Inc. He completed his undergraduate studies at Delaware Valley University and New York University, and his graduate studies at Seton Hall University.
He also completed another undergraduate degree at Widener University.
Ehemalige bekannte Positionen von Douglas N. Dobak
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | General Counsel | - |
| NPS PHARMACEUTICALS, INC. | General Counsel | - |
Ausbildung von Douglas N. Dobak
| Delaware Valley University | Undergraduate Degree |
| Seton Hall University | Graduate Degree |
| New York University | Undergraduate Degree |
| Widener University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |